Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials

OBJECTIVES: Several randomized controlled trials (RCTs) consistently reported better clinical outcomes with radial as compared to femoral access for primary percutaneous coronary intervention (PCI). Nevertheless, heterogeneous use of potent antiplatelet drugs, such as Gp IIb/IIIa inhibitors (GPI), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigattieri, Stefano, Cristiano, Ernesto, Giovannelli, Francesca, Tommasino, Antonella, Cava, Francesco, Citoni, Barbara, Zardi, Domenico Maria, Berni, Andrea, Volpe, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221896/
https://www.ncbi.nlm.nih.gov/pubmed/34220370
http://dx.doi.org/10.1155/2021/9917407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221896/
https://www.ncbi.nlm.nih.gov/pubmed/34220370
http://dx.doi.org/10.1155/2021/9917407

Ejemplares similares